Serial Number 88696552
Registration 6969474
700

Registration Progress

Application Filed
Nov 18, 2019
Under Examination
Jun 2, 2020
Approved for Publication
Apr 7, 2020
Published for Opposition
Apr 7, 2020
Registered
Jan 31, 2023

Trademark Image

Basic Information

Serial Number
88696552
Registration Number
6969474
Filing Date
November 18, 2019
Registration Date
January 31, 2023
Published for Opposition
April 7, 2020
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 31, 2023
Registration
Registered
Classes
005

Rights Holder

SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO., LTD

99
Address
ROOM 3301-3302
1027 CHANGNING ROAD, CHANGNING DISTRICT
SHANGHAI 200050
CN

Ownership History

SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO., LTD

Original Applicant
99
SHANGHAI CN

SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO., LTD

Owner at Publication
99
SHANGHAI CN

SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO., LTD

Original Registrant
99
SHANGHAI CN

Legal Representation

Attorney
Gang Luo

USPTO Deadlines

Next Deadline
1283 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-31)
Due Date
January 31, 2029
Grace Period Ends
July 31, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Jan 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 28, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 27, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 13, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 13, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 29, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 29, 2022 IUAF S USE AMENDMENT FILED Loading...
Jun 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 31, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
May 31, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 25, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 23, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 23, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 23, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 1, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 1, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 1, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 2, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 18, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 4, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 26, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 26, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 26, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 26, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 26, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 21, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 26, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 23, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines for human purposes for the treatment of liver disease; pharmaceutical preparations for the treatment of cervical spondylopathy; medicinal herbs; medicinal herbal preparations for the treatment of climacteric syndrome; sanitary sterilizing preparations; dietetic preparations adapted for medical use, namely, nutritional supplements; depuratives for the body; medicines for veterinary purposes, namely, veterinary preparations for the treatment of digestive tract inflammation; first aid kits
First Use Anywhere: Nov 8, 2019
First Use in Commerce: Nov 8, 2019

Additional Information

Design Mark
The mark consists of an incomplete circular design formed by two concentric curved lines. The exterior curved line features a clockwise or right-facing arrow at the end, and the interior curved line features a counterclockwise or left-facing arrow at the end. A solid shaded circle appears in the center of the circular design. To the right of the circular design appears horizontally arranged Chinese characters.
Color Claim
Color is not claimed as a feature of the mark.
Other
The non-Latin characters in the mark transliterate to "FUZHENGHUAYU" and this means "STRENGTHENING THE BODY RESISTANCE AND ELIMINATING BLOOD STASIS" in English.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO FUZHENGHUAYU